Clinical Trial

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

Name: A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors — clinical trial record (NCT07136142)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of FH-006 in subjects with advanced malignant solid tumors, and determine the preliminary efficacy.

Trial Details

NCT Number	NCT07136142
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Malignant Solid Tumor
Enrollment	150 participants
Start Date	2025-08
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2025-08-22